194 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
on investments in science and innovation, technology-enabled operations, an elevated customer experience, strong commercial execution, and scalable … , freeing up the field sales team to target higher potential clinical leads. We believe inside sales can be more cost effective in terms of customer
8-K
EX-99.1
v2nas3
16 Jan 24
Results of Operations and Financial Condition
9:00am
8-K
EX-10.1
u5k9mnds8zktwg
1 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
bcwj63 8cyd4v3076ps
5 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.2
xdjl15
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
8-K
EX-10.1
mei2cuic hqn
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
ARS
hjg3qzcaj
12 Apr 23
Annual report to shareholders
4:10pm
8-K
vi8kyp xo
4 Aug 22
Myriad Genetics Reports Second Quarter Financial Results
7:06am
8-K
EX-99.1
eyrjvnmzk
4 Aug 22
Myriad Genetics Reports Second Quarter Financial Results
7:06am